Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
3.970
+0.220 (5.87%)
At close: Sep 17, 2026, 4:00 PM EDT
4.001
+0.031 (0.78%)
After-hours: Sep 17, 2026, 7:55 PM EDT
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $2.03 million as of September 17, 2026. Its market cap has decreased by -55.38% in one year.
Market Cap
2.03M
Enterprise Value
-2.12M
1-Year Change
-55.38%
Ranking
Category
Stock Price
$3.97
ChartMarket Cap Chart
Since November 14, 2017, Artelo Biosciences's market cap has decreased from $5.87M to $2.03M, a decrease of -65.47%. That is a compound annual growth rate of -11.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 2.03M | -17.70% |
| Dec 31, 2025 | 2.46M | -28.02% |
| Dec 31, 2024 | 3.42M | -23.36% |
| Dec 29, 2023 | 4.46M | -45.90% |
| Dec 30, 2022 | 8.25M | -62.41% |
| Dec 31, 2021 | 21.95M | 99.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Matinas BioPharma Holdings | 2.43M |
| Curis | 2.33M |
| Tessera Defense and Homeland Security | 2.28M |
| Oragenics | 2.26M |
| Virax Biolabs Group | 2.02M |
| Valion Bio | 1.90M |
| Propanc Biopharma | 1.90M |
| Decoy Therapeutics | 1.84M |